Malignant mixed Mullerian tumor

Search Trials
Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors
Status:
Completed
Last Changed:
Jul 27, 2018
First Changed:
Aug 23, 2007
Disease(s):
Ovarian Cancer
Intervention(s):
bevacizumaberlotinibpaclitaxelcarboplatin
Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient
Status:
No longer available
Last Changed:
Jul 29, 2015
First Changed:
Mar 18, 2014
Disease(s):
Mullerian Mixed Tumor of Ovary
Intervention(s):
ficlatuzumab
Suitability of DCE-MRI for Detection of Vascular Changes After VBT
Status:
Unknown status
Last Changed:
Apr 13, 2016
First Changed:
Nov 25, 2013
Disease(s):
Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus
Intervention(s):
Radiotherapy
Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?
Status:
Recruiting
Last Changed:
Oct 22, 2018
First Changed:
Jun 27, 2018
Disease(s):
Carcinosarcoma
Intervention(s):
PaclitaxelCediranibOlaparib
microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer
Status:
Unknown status
Last Changed:
Nov 16, 2016
First Changed:
Nov 16, 2016
Disease(s):
Prostate Carcinosarcoma
Intervention(s):
High PSA levels

Connect. Empower. Inspire.